AMR Conference: 26-27th April 2018 SULSA s Antimicrobial Resistance Conference Event Programme Day One: Research Day Two: Policy Thursday 26th Friday 27th April 2018 Technology and Innovation Centre Glasgow www.sulsa.ac.uk 1
SULSA The Scottish Universities Life Science Alliance (SULSA) is a strategic alliance between nine Scottish Universities that aims to enhance Scotland s vibrant life sciences research community by improving opportunities for collaboration, innovation, funding and translational research. In doing so, we seek to increase the level of high quality life sciences research being conducted in Scotland and improve Scotland s global reputation in the life sciences. 2
Dear Delegate, I would like to personally welcome you to SULSA s Antimicrobial Resistance Conference. This is our first conference for some time and I m thrilled to say we sold out. This shows the breadth and strength of interest in antimicrobial resistance (AMR) in Scotland. Antimicrobial resistance is one of the major challenges facing the world today. With the UK AMR strategy being refreshed this year, it is a perfect time to bring together major players in the AMR scene to showcase, discuss, challenge and plan how we can work together to address this huge issue. Over the next two days you will hear from researchers, industry, public health workers and clinicians, funders and government who will present their research, knowledge and experience in their areas. We have scheduled thought-provoking panel discussions and breakout sessions so that you can delve into specific topics in more depth. The poster sessions will enable you to see even more of the exciting AMR research taking place in Scotland. One of SULSA s main aims is to support researchers from around Scotland to collaborate together more effectively and successfully. To help achieve this, we will be launching a seed-funding call for delegates after the conference, and we hope these new projects and collaborations will spark long-standing, effective and fruitful research programmes. I ask that you participate throughout the conference and help us shape the future of AMR research in Scotland. Professor Mike Barrett SULSA Director #sulsa AMR 3
ANTIMICROBIAL RESISTANCE Is an antimicrobial resistance Armageddon upon us? Are the drugs that have kept infectious agents at bay for decades about to fail? An influential UK government report has predicted that by 2050 we might be seeing as many as 10 million deaths globally caused by antimicrobial resistant infections which will also place an annual economic burden on societies running as high as a hundred trillion pounds per year. For over 60 years we have taken it for granted that we are unlikely to be killed by bacterial infections. Just 100 years ago, diseases like tuberculosis, typhoid, cholera, bacterial pneumonia and sepsis accounted for around half of all deaths. Average life expectancy is now twice what it was back then. This change can be attributed, in part, to a serendipitous discovery by a young Scottish doctor, Alexander Fleming, from Darvel in Ayrshire, who is credited with discovering a class of chemicals that we now call antibiotics back in 1928. Before Fleming, Lord Lister, professor of medicine at Glasgow University in the mid-nineteenth Century, had introduced chemical antisepsis as the first major effort to stem infection. Scotland remains at the forefront of research into antimicrobial resistance and our Universities, in conjunction with several innovative companies, are again pioneering efforts to confront the impending crisis in antimicrobial resistance. See our SULSA War on Germs article in your delegate bag for more of the story! 4
GENERAL INFORMATION Cloakroom There is a storage area on Level 2 at the left hand side of the exhibition area for luggage, coats and umbrellas. Please note that items left in this area are at the owner s risk. SULSA accepts no responsibility for property which is lost, stolen or damaged. Social Media Follow us @SULSAtweets and join the conversation using #sulsaamr Wi-Fi Wi-Fi access is available throughout the Technology & Innovation Centre and the University campus free of charge. Delegates can connect to the internet via _The Cloud. Delegates from academic institutions should also be able to access Wi-Fi via Eduroam, using login details from their home institution. Using _The Cloud: select WiFi Guest from the list of your available networks launch your preferred browser and click Get Online select the Free Wi-Fi Cloud option if you have used _The Cloud elsewhere before you can use the same credentials. If not, select Create Account and enter all mandatory information requested select Continue Additional Venues Glasgow City Chambers - George Square The Anchor Line Restaurant - 12 St Vincent Place #sulsa AMR 5
PROGRAMME DAY 1 RESEARCH 09.00-09.45 Arrival, Coffee and Registration Foyer Level 2 09.45-09.55 Introduction with Professor Mike Barrett, SULSA Director 10.00-10.20 Professor Neil Gow, University of Aberdeen Medical Mycology and AMR: A Rapidly Emerging Problem and Global Health Challenge 10.25-10.45 Dr Clare Taylor, Edinburgh Napier University Applying Microbiology to the Antimicrobial Problem 10.50-11.10 Professor Mark Woolhouse, University of Edinburgh Is There a Link Between Antibiotic Usage in Livestock and AMR in Human Patients? 11.10-11.50 Coffee Break Foyer Level 2 11.50-12.10 Dr Katherine Duncan, University of Strathclyde Omics Guided Antibiotic Discovery from Our Oceans 12.15-12.35 Professor Ian Gilbert, University of Dundee Challenges in Antibacterial Drug Discovery 12.40-13.00 Dr Deborah O Neil, Novabiotics Novel, Immune System Based Approaches to Tackling AMR 13.00-14.30 Lunch and Poster Session (Odd Numbers) Foyer Level 2 14.30-14.50 Dr Till Bachmann, University of Edinburgh Rapid Diagnostics to Combat Antimicrobial Resistance 14.55-15.15 Dr Alison Mather, Quadram Institute Whole Genome Sequencing to Understand the Epidemiology and Transmission of Antimicrobial Resistance 15.20-15.40 Professor Colin J Suckling, University of Strathclyde Strathclyde Minor Groove Binders (S-MGBs), A Family of Anti-Infective Agents 15.40-16.10 Coffee Break Foyer Level 2 16.10-16.50 Panel Discussion with Q&A Chair: Professor Mike Barrett The war: is an AMR Armageddon really upon us, or are reports exaggerated? 16.50-17.50 Poster Session (Even Numbers) Foyer Level 2 18.00-19.00 Civic Reception at Glasgow City Chambers 19.15-21.00 Conference Dinner at The Anchor Line 6
PROGRAMME DAY 2 POLICY 09.00-09.40 Arrival, Coffee and Registration Foyer Level 2 09.45-09.50 Introduction with Professor Frank Gunn-Moore, SULSA Deputy Director 09.55-10.15 Professor Mike Turner, Wellcome Trust Funding for Antimicrobial Resistance Research at Wellcome 10.20-10.40 Dr Jonathan Pearce, MRC AMR A Cross-Disciplinary and Global Challenge 10.45-11.00 Dr Catherine Calderwood Chief Medical Officer for Scotland 11.00-11.40 Coffee Break Foyer Level 2 11.40-12.00 Professor Dilip Nathwani OBE, University of Dundee Global and UK Epidemiology and Burden of Multi-Drug Resistant Bacteria 12.05-12.25 Dr Eleanor Anderson, Health Protection Scotland Control of AMR in Scotland 12.30-12.50 George Leahy, Public Health England Shaping PHE s Role in the Development of the Next 5 Year Action Plan 12.50-13.30 Panel Discussion with Q&A Chair: Dr Paul Herron New weapons: How can changing approaches help us conquer AMR? 13.30-14.30 Lunch Foyer Level 2 14.30-15.30 Breakout Session 1 (see page 8) See page 8 15.30-16.30 Breakout Session 2 (see page 8) See page 8 16.30 Prizes, Funding Call Launch and Close Foyer Level 2 7
BREAKOUT SESSIONS Session 1 2.30-3.30pm Option 1 - Speeding the Antibiotic Discovery Pipeline Chair: Professor Ian Gilbert Room:, Level 2 Option 2 - Clinical Considerations in AMR Chair: Professor Dilip Nathwani Room: Conference Room 6, Level 3 Option 3 - A One Health Approach to Tackling AMR Chair: Professor Dominic Mellor Room: Conference Room 7, Level 3 Session 2 3.30-4.30pm Option 1 - Maximising Funding Opportunities for AMR Research Chair: Dr Nicholas Tucker Room:, Level 2 Option 2 - Diagnostics Chair: Professor Stephen Gilliespie Room: Conference Room 6, Level 3 Option 3 - Public Health Considerations in Dealing with AMR Chair: Dr Eleanor Anderson Room: Conference Room 7, Level 3 Please note: the above content was correct at time of printing. Any changes to sessions and rooms will be displayed outside conference rooms 6 and 7 on level 3. 8
SEED FUNDING SULSA is delighted to launch our AMR seed funding call to fund small grants aimed at forming new collaborations to address challenges surrounding antimicrobial resistance. Purpose: This funding is to enable researchers to gather preliminary data and develop proposals with the aim of attracting further funding from external sources. Eligibility: Registered participants (post-doctoral researchers and above) from the conference will be eligible for this call, and there must be co-applicants from at least two SULSA member universities. Funding Available: a maximum of 8,000 per successful application is available and will be for a 12-month project. How to Apply: please visit www.sulsa.ac.uk/funding to apply before Friday 1st June 2018. The SULSA AMR committee will review all applications. Apply before 1st June! 9
GLASGOW POLYOMICS At Glasgow Polyomics we offer the collection and analysis of omics datasets. Our high level technical expertise allows us to collect and process high quality data on whole genomes, transcriptomes, proteomes, and metabolomes. Our skilled laboratory, informatics and administrative staff can support you at every stage of your project from planning to publication! This includes support for: Experimental design Grant applications Development of bespoke methods Provision of bespoke analyses Statistical interpretation of data 10 For enquires please email: polyomics@glasgow.ac.uk or enquire via our website at www.polyomics.gla.ac.uk/enquiry
Complete IP services for life sciences IP is a valuable asset and can be the key to competitive advantage. We can help you get the right advice on identifying, protecting and exploiting your intellectual assets at a cost that suits you. With eight offices in the UK and an impressive international network, we re here to help your ideas take off. Due diligence and advice on using IP in business financing deals Global portfolio protection, enforcement and litigation Portfolio management IP valuation and strategy Guidance on commercialisation and licensing 11
)LQG RXW PRUH DERXW WKH 0LFURELRORJ\ 6RFLHW\ Grants Networking opportunities Professional development Publishing your research PLFURELRORJ\VRFLHW\ RUJ 12 MSUntitled-1 Impactful Conference Stand Advert.indd 1 1 02/08/2017 14:17 02/08/2017 14:20
NOTES 13
14